LABP [NASD]
Landos Biopharma, Inc.
Index- P/E- EPS (ttm)-1.07 Insider Own32.93% Shs Outstand40.25M Perf Week-13.21%
Market Cap26.89M Forward P/E- EPS next Y-1.37 Insider Trans-3.83% Shs Float30.40M Perf Month-46.72%
Income-38.40M PEG- EPS next Q-0.31 Inst Own66.70% Short Float0.85% Perf Quarter-66.83%
Sales18.00M P/S1.49 EPS this Y-36.10% Inst Trans-0.04% Short Ratio2.66 Perf Half Y-95.49%
Book/sh1.90 P/B0.36 EPS next Y-62.20% ROA-27.80% Target Price20.46 Perf Year-94.19%
Cash/sh2.29 P/C0.30 EPS next 5Y- ROE-31.50% 52W Range0.61 - 16.17 Perf YTD-85.90%
Dividend- P/FCF- EPS past 5Y- ROI-50.90% 52W High-95.94% Beta-
Dividend %- Quick Ratio5.50 Sales past 5Y- Gross Margin- 52W Low8.45% ATR0.12
Employees46 Current Ratio5.50 Sales Q/Q- Oper. Margin- RSI (14)28.22 Volatility19.17% 13.99%
OptionableNo Debt/Eq0.00 EPS Q/Q-76.60% Profit Margin- Rel Volume0.67 Prev Close0.68
ShortableYes LT Debt/Eq0.00 EarningsMay 12 AMC Payout- Avg Volume97.54K Price0.66
Recom2.30 SMA20-29.11% SMA50-49.46% SMA200-91.10% Volume29,810 Change-2.94%
Apr-12-22Downgrade Jefferies Buy → Hold $30 → $1.40
Nov-16-21Downgrade SVB Leerink Outperform → Mkt Perform $20 → $16
Oct-20-21Initiated Craig Hallum Buy $45
Oct-19-21Initiated H.C. Wainwright Buy $50
Mar-01-21Initiated SVB Leerink Outperform $20
Mar-01-21Initiated Raymond James Outperform $33
Mar-01-21Initiated JP Morgan Neutral $17
Mar-01-21Initiated Jefferies Buy $32
May-13-22 08:28AM  
May-12-22 04:05PM  
May-11-22 07:32AM  
May-08-22 09:00AM  
Mar-24-22 04:45PM  
Mar-10-22 08:00AM  
Feb-04-22 07:23AM  
Nov-17-21 08:33AM  
Nov-15-21 07:30AM  
Nov-11-21 04:05PM  
Nov-10-21 08:32AM  
Nov-08-21 08:10AM  
Nov-02-21 08:28AM  
Oct-28-21 07:00AM  
Oct-15-21 08:49AM  
Oct-11-21 07:00AM  
Oct-06-21 07:00AM  
Sep-27-21 07:00AM  
Sep-20-21 07:00AM  
Sep-15-21 07:00AM  
Sep-01-21 07:00AM  
Aug-26-21 07:00AM  
Aug-19-21 03:03PM  
Aug-05-21 07:00AM  
Jul-22-21 07:00AM  
Jun-14-21 05:08PM  
07:00AM  
May-25-21 07:00AM  
May-19-21 07:00AM  
May-17-21 09:29AM  
07:15AM  
07:00AM  
May-06-21 04:01PM  
May-04-21 08:51AM  
Apr-29-21 07:00AM  
Apr-26-21 11:56AM  
07:00AM  
Apr-13-21 07:00AM  
Apr-06-21 09:53AM  
07:00AM  
Mar-04-21 07:00AM  
Feb-26-21 06:26PM  
Feb-23-21 04:00PM  
Feb-05-21 05:26PM  
Feb-04-21 05:56PM  
Feb-03-21 08:13PM  
Landos Biopharma, Inc., a clinical-stage biopharmaceutical company, discovers and develops oral therapeutics for patients with autoimmune diseases. Its lead product candidate in development is BT-11, an oral lanthionine synthetase C-like protein 2 (LANCL2) agonist for the treatment of ulcerative colitis (UC), Crohn's disease (CD), and inflammatory bowel diseases. The company also develops NX-13, a gut-restricted oral therapeutic that targets NOD-like receptor X1, a mitochondria-associated receptor associated with the modulation of inflammatory cytokines for UC and CD; and PX-69, an oral PLXDC2 agonist for the treatment of diabetic nephropathy and rheumatoid arthritis. Landos Biopharma, Inc. was incorporated in 2017 and is headquartered in Blacksburg, Virginia.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bassaganya-Riera Josep10% OwnerDec 20Sale4.7533,194157,8044,994,208Dec 20 05:20 PM
Bassaganya-Riera Josep10% OwnerDec 17Sale4.8436,000174,0965,027,402Dec 20 05:20 PM
Bassaganya-Riera Josep10% OwnerDec 16Sale5.1124,301124,2515,063,402Dec 20 05:20 PM
Bassaganya-Riera Josep10% OwnerDec 15Sale5.0243,000216,0325,146,354Dec 15 05:14 PM
Bassaganya-Riera Josep10% OwnerDec 14Sale5.1042,000214,2845,189,354Dec 15 05:14 PM
Bassaganya-Riera Josep10% OwnerDec 13Sale5.3740,000214,8405,231,354Dec 15 05:14 PM
Bassaganya-Riera Josep10% OwnerDec 10Sale5.7740,000230,8005,271,354Dec 10 08:06 PM
Bassaganya-Riera Josep10% OwnerDec 09Sale6.2611,16269,8295,311,354Dec 10 08:06 PM
Bassaganya-Riera Josep10% OwnerDec 08Sale6.6525,530169,7235,322,516Dec 08 05:22 PM
Bassaganya-Riera Josep10% OwnerDec 07Sale6.5842,000276,5285,348,046Dec 08 05:22 PM
Bassaganya-Riera Josep10% OwnerDec 06Sale6.1736,000221,9765,390,046Dec 08 05:22 PM
Bassaganya-Riera Josep10% OwnerDec 03Sale6.1536,000221,3647,295,054Dec 03 06:35 PM
Bassaganya-Riera Josep10% OwnerDec 02Sale6.4529,861192,6337,331,054Dec 03 06:35 PM
Bassaganya-Riera Josep10% OwnerDec 01Sale7.0132,237226,1107,360,915Dec 03 06:35 PM
Bassaganya-Riera Josep10% OwnerNov 30Sale7.0635,000247,1707,393,152Dec 01 09:57 PM
Bassaganya-Riera Josep10% OwnerNov 29Sale7.5815,430116,8827,428,152Dec 01 09:57 PM
Chauhan JyotiED, Global Clinical OperationsJul 26Option Exercise1.86118,054219,580209,299Nov 18 04:07 PM